Celltrion Healthcare Co Ltd
KOSDAQ:091990
Intrinsic Value
Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. [ Read More ]
The intrinsic value of one Celltrion Healthcare Co Ltd stock under the Base Case scenario is 62 877.97 KRW. Compared to the current market price of 75 900 KRW, Celltrion Healthcare Co Ltd is Overvalued by 17%.
Valuation Backtest
Celltrion Healthcare Co Ltd
Run backtest to discover the historical profit from buying and selling Celltrion Healthcare Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Celltrion Healthcare Co Ltd's business.
What risks and challenges
does Celltrion Healthcare Co Ltd face in the near future?
Summarize the latest earnings report
of Celltrion Healthcare Co Ltd.
Provide P/E
for Celltrion Healthcare Co Ltd and its competitors.
Balance Sheet Decomposition
Celltrion Healthcare Co Ltd
Current Assets | 4.5T |
Cash & Short-Term Investments | 433.4B |
Receivables | 1.3T |
Other Current Assets | 2.7T |
Non-Current Assets | 182.2B |
Long-Term Investments | 2.8B |
PP&E | 10.3B |
Intangibles | 12.3B |
Other Non-Current Assets | 156.8B |
Current Liabilities | 2.5T |
Accounts Payable | 1.7T |
Accrued Liabilities | 87.5B |
Short-Term Debt | 292.5B |
Other Current Liabilities | 447.2B |
Non-Current Liabilities | 135.8B |
Long-Term Debt | 4.6B |
Other Non-Current Liabilities | 131.3B |
Earnings Waterfall
Celltrion Healthcare Co Ltd
Revenue
|
2.1T
KRW
|
Cost of Revenue
|
-1.4T
KRW
|
Gross Profit
|
620.7B
KRW
|
Operating Expenses
|
-425.9B
KRW
|
Operating Income
|
194.8B
KRW
|
Other Expenses
|
-58.9B
KRW
|
Net Income
|
136B
KRW
|
Free Cash Flow Analysis
Celltrion Healthcare Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Celltrion Healthcare Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Celltrion Healthcare Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Celltrion Healthcare Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Score
Celltrion Healthcare Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Celltrion Healthcare Co Ltd
According to Wall Street analysts, the average 1-year price target for Celltrion Healthcare Co Ltd is 97 444 KRW .
Shareholder Return
Price
Celltrion Healthcare Co Ltd
Average Annual Return | 26.22% |
Standard Deviation of Annual Returns | 112.09% |
Max Drawdown | -68% |
Market Capitalization | 12.2T KRW |
Shares Outstanding | 164 460 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. The company is headquartered in Incheon, Incheon. The company went IPO on 2017-07-28. The firm provides Remsima, an infliximab biosimilar used for the treatment of rheumatoid arthritis, ankylosing spondylitis, adult and child crohn’s disease, psoriasis, psoriatic arthritis and ulcerative colitis. The company also offers Truxima, a rituximab biosimilar used for the treatment of non-Hodgkin lymphomas, chronic lymphocytic leukemia and rheumatoid arthritis. The firm distributes its products in domestic and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Celltrion Healthcare Co Ltd stock under the Base Case scenario is 62 877.97 KRW.
Compared to the current market price of 75 900 KRW, Celltrion Healthcare Co Ltd is Overvalued by 17%.